Alterity Therapeutics Limited
ATH
Rank in Stocks
#25472
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Share Price
$0.21511186
Last synced: 2026-10-16
Market Cap
$47.00M
Change (1 day)
0.00%
Change (1 year)
-38.54%
Country
AU
Trade Alterity Therapeutics Limited (ATH)
Category
Healthcare
Operating Margin for Alterity Therapeutics Limited (ATH)
Operating Margin as of 2026 TTM: 0.00%
According to Alterity Therapeutics Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Alterity Therapeutics Limited from 2026 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.